John Medland

This profile gathers the share dealings of John Medland in MediPharm Labs Corp. Over a trading history stretching from 16 June 2025 to 9 June 2026, the count stands at 5 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 16 June 2026, reports an option exercise in MediPharm Labs Corp. Between a trade and the moment it shows up on SEDI, the median delay is 7 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.